Verus Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Verus Capital Partners's AMGN Position: Q1 2026 in Review
Verus Capital Partners increased its Amgen (AMGN) stake by 1.5% in Q1 2026, buying an estimated $6.06K and bringing the position to 1,161 shares worth $409K. The position accounts for 0.03% of the portfolio, ranked #307.
Verus Capital Partners first reported a position in AMGN in Q4 2019 and has held it in 19 quarters since. The position peaked at $746K in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Verus Capital Partners held 1,161 shares of Amgen worth $409K as of Q1 2026.
- Verus Capital Partners bought 17 Amgen shares in Q1 2026, an estimated $6.06K.
- Amgen made up 0.03% of Verus Capital Partners's portfolio in Q1 2026, its #307 holding.
- Verus Capital Partners first reported a position in Amgen in Q4 2019 and has held it in 19 quarters since.
- Verus Capital Partners's Amgen position peaked at $746K in Q3 2024.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.